Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like FDA Grants Priority Review for Liso-Cel in B-cell Lymphoma February 24, 2020 J&J Partners With Emergent to Produce COVID-19 Vaccine April 23, 2020 EU Signs COVID-19 Vaccine Supply Deal With Sanofi/GSK September 20, 2020